Authors: Liang L, Zhang Y, Ma Y, Liu J, Du W, Ma Q.
DOI: 10.3389/fphar.2025.1706048
Abstract Summary
Propranolol, the first-line treatment for infantile hemangiomas, works by rebalancing disrupted angiogenic proteins. Researchers found 26 proteins were abnormally low in untreated patients; after 3 months of therapy, 6 key proteins normalized, affecting pathways controlling blood vessel growth and cell proliferation. These findings reveal propranolol’s mechanism and identify potential biomarkers for monitoring treatment success.
Why Brain? ðŸ§
Propranolol therapy for infantile hemangiomas restores balance to dysregulated angiogenic proteins, offering new insights into treatment mechanisms and potential biomarkers for monitoring response.
License: CC BY.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
